Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Riegler

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel diseaseMario Cottone, Anna Kohn, Marco Daperno, et al.
Inflammatory Bowel Diseases|August 5, 2010
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair studyLivia Biancone, Carmelina Petruzziello, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|January 9, 2007
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's diseaseFrancesca Bresso, Johan Askling, Marco Astegiano, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]Pietro Manuel Ferraro, Valeria D'Ovidio, Giampaolo Bresci, et al.
Journal of Clinical Apheresis|November 11, 2011
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric studyStefano Passalacqua, Pietro Manuel Ferraro, Giampaolo Bresci, et al.
Gastroenterology|September 15, 2007
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel diseaseMauro D'Amato, Sara Bruce, Francesca Bresso, et al.
Journal of Crohn'S & Colitis|March 3, 2016
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Cancers|February 15, 2022
Incident Colorectal Cancer in Inflammatory Bowel DiseaseBenedetto Neri, Maria Lia Scribano, Alessandro Armuzzi, et al.
Inflammatory Bowel Diseases|September 10, 2019
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2010
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel diseaseMario Cottone, Anna Kohn, Marco Daperno, et al.
Inflammatory Bowel Diseases|August 5, 2010
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair studyLivia Biancone, Carmelina Petruzziello, Ambrogio Orlando, et al.
Inflammatory Bowel Diseases|January 9, 2007
Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's diseaseFrancesca Bresso, Johan Askling, Marco Astegiano, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 6, 2012
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]Pietro Manuel Ferraro, Valeria D'Ovidio, Giampaolo Bresci, et al.
Journal of Clinical Apheresis|November 11, 2011
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric studyStefano Passalacqua, Pietro Manuel Ferraro, Giampaolo Bresci, et al.
Gastroenterology|September 15, 2007
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel diseaseMauro D'Amato, Sara Bruce, Francesca Bresso, et al.
Journal of Crohn'S & Colitis|March 3, 2016
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Cancers|February 15, 2022
Incident Colorectal Cancer in Inflammatory Bowel DiseaseBenedetto Neri, Maria Lia Scribano, Alessandro Armuzzi, et al.
Inflammatory Bowel Diseases|September 10, 2019
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Pageof 6